Conjunctivitis: Clinical Trials

7 trials for Conjunctivitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 withdrawn. 7 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Withdrawn 7
Phase 32Withdrawn 2

Follow Conjunctivitis: new trials by email Literature Review of Conjunctivitis trials Research Report on Conjunctivitis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Grass-SPIRE Registration Study
Grass-SPIRE, Placebo - Rhinitis, Conjunctivitis
Phase 2 / Phase 3WithdrawnCircassia Limited2016-05-012016-06-23
Nepal Elimination of Trachoma Study
Azithromycin - Trachoma
Phase 2 / Phase 3WithdrawnUniversity of California, San Francisco2014-08-012015-05-21
Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis
PRO-118 Ophthalmic Solution 0.015%, PRO-118 Ophthalmic Solution 0.015 %, PRO-118 Ophthalmic Solution 0.020 % - Ocular Itching, Ocular Allergy
Phase 2WithdrawnLaboratorios Sophia S.A de C.V.2011-03-012018-10-02
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
AL-15469A 0.5% and AL-6515 0.3% Ophthalmic Suspension, AL-15469A 0.5%, AL-6515 0.3% - Bacterial Conjunctivitis
Phase 2WithdrawnAlcon Research2011-01-012011-12-01
A Study Of Tasocitinib In Dry Eye Subjects
Tasocitinib, vehicle for Tasocitinib - Keratoconjunctivitis Sicca
Phase 2WithdrawnPfizer2010-12-012018-11-29
To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge
AL38583 Ophthalmic Solution, Maxidex, Vehicle - Allergic Conjunctivitis
Phase 2WithdrawnAlcon Research2009-05-012012-03-06
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
Ketotifen/vasoconstrictor - Allergic Conjunctivitis
Phase 2WithdrawnBausch & Lomb Incorporated2015-02-20

Narrower conditions

Conjunctivitis, Allergic (3)  ·  Conjunctivitis, Bacterial (1)  ·  Dry Eye Syndromes (1)  ·  Hypersensitivity (1)  ·  Keratoconjunctivitis Sicca (1)  ·  Rhinitis (1)  ·  Trachoma (1)

Broader conditions

Conjunctival Diseases (7)  ·  Eye Diseases (7)  ·  Immune System Diseases (4)  ·  Hypersensitivity (3)  ·  Hypersensitivity, Immediate (3)  ·  Infections (3)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Corneal Diseases (2)  ·  Eye Infections (2)  ·  Eye Infections, Bacterial (2)  ·  Chlamydia Infections (1)  ·  Chlamydiaceae Infections (1)  ·  Conjunctivitis, Bacterial (1)

Interventions

Azithromycin (1)  ·  Dexamethasone (1)  ·  Ketotifen (1)  ·  Vasoconstrictor Agents (1)  ·  tofacitinib (1)

Sponsors

Alcon Research (2)  ·  Bausch & Lomb Incorporated (1)  ·  Circassia Limited (1)  ·  Laboratorios Sophia S.A de C.V. (1)  ·  Pfizer (1)  ·  University of California, San Francisco (1)

Countries

Mexico (1)  ·  Nepal (1)  ·  United States (1)

Top investigators

Bruce D Gaynor, MD (1)  ·  David Bernstein, MD (1)  ·  Miriam Becerra-Cotta, MD (1)

NIH funding

K23EY019881 (1)